FCCC LOGO Faculty Publications
Cahn DB , Ristau BT , Ghiraldi EM , Churilla TM , Geynisman DM , Horwitz EM , Uzzo RG , Smaldone MC
Bladder Preservation Therapy: A Review of the Literature and Future Directions
Urology. 2016 Oct;96 :54-61
Back to previous list
Abstract
Trimodal bladder preservation therapy (ie, transurethral resection followed by chemoradiotherapy) may be an acceptable treatment alternative to radical cystectomy with urinary diversion in the carefully selected patient with muscle invasive bladder cancer. Although no head-to-head randomized controlled trials have been performed, large retrospective cohort reviews and observational data analyses suggest comparable oncologic outcomes in select patients with the additional benefit of maximizing quality of life and maintaining the patient's native bladder. In this review, we discuss the evolution and clinical outcomes of bladder preservation therapy, highlighting its role in the contemporary management of muscle invasive bladder cancer.
Notes
Cahn, David B Ristau, Benjamin T Ghiraldi, Eric M Churilla, Thomas M Geynisman, Daniel M Horwitz, Eric M Uzzo, Robert G Smaldone, Marc C eng Review Urology. 2016 Oct;96:54-61. doi: 10.1016/j.urology.2016.05.041. Epub 2016 May 30.